MeSH Review:
Neostriatum
- Huntington disease associated with Alzheimer disease. McIntosh, G.C., Jameson, H.D., Markesbery, W.R. Ann. Neurol. (1978)
- Differential receptor occupancy requirements for muscarinic cholinergic stimulation of inositol lipid hydrolysis in brain and in neuroblastomas. Fisher, S.K., Snider, R.M. Mol. Pharmacol. (1987)
- Effect of insulin-induced hypoglycemia on the concentrations of glutamate and related amino acids and energy metabolites in the intact and decorticated rat neostriatum. Engelsen, B., Westerberg, E., Fonnum, F., Wieloch, T. J. Neurochem. (1986)
- Gender difference in dopamine concentration and postischemic neuronal damage in neostriatum after unilateral dopamine depletion. Xu, Z.C., Chwang, W., Li, X., Chen, X., He, P. Exp. Neurol. (1999)
- Selective retention of MPP+ within the monoaminergic systems of the primate brain following MPTP administration: an in vivo autoradiographic study. Herkenham, M., Little, M.D., Bankiewicz, K., Yang, S.C., Markey, S.P., Johannessen, J.N. Neuroscience (1991)
- Nigral transplants reinnervating the dopamine-depleted neostriatum can sustain intracranial self-stimulation. Fray, P.J., Dunnett, S.B., Iversen, S.D., Björklund, A., Stenevi, U. Science (1983)
- Sedative effects of apomorphine in an animal model of Huntington's disease. Sanberg, P.R., Lehmann, J., Fibiger, H.C. Arch. Neurol. (1979)
- Sensorimotor impairment and elevated levels of dopamine metabolites in the neostriatum occur rapidly after intranigral injection of 6-hydroxydopamine or gamma-hydroxybutyrate in awake rats. Altar, C.A., O'Neil, S., Marshall, J.F. Neuropharmacology (1984)
- Extracellular adenosine levels in neostriatum and hippocampus during rest and activity periods of rats. Huston, J.P., Haas, H.L., Boix, F., Pfister, M., Decking, U., Schrader, J., Schwarting, R.K. Neuroscience (1996)
- Neurochemical changes in mice following physical or psychological stress exposures. Sutoo, D., Akiyama, K. Behav. Brain Res. (2002)
- Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors. Heikkila, R.E., Manzino, L., Cabbat, F.S., Duvoisin, R.C. Nature (1984)
- Dopamine modulates cholecystokinin release in neostriatum. Meyer, D.K., Krauss, J. Nature (1983)
- In vivo electrochemical detection of catechols in the neostriatum of anaesthetized rats: dopamine or DOPAC? Gonon, F., Buda, M., Cespuglio, R., Jouvet, M., Pujol, J.F. Nature (1980)
- Enkephalin and opiate narcotics increase cyclic GMP accumulation in slices of rat neostriatum. Minneman, K.P., Iversen, I.L. Nature (1976)
- Forebrain lesions disrupt development but not maintenance of song in passerine birds. Bottjer, S.W., Miesner, E.A., Arnold, A.P. Science (1984)
- Morphologic evidence of a primary response of gila to kainic acid administration into the rat neostriatum; studied in vivo and in vitro. Matyja, E. Exp. Neurol. (1986)
- Muscular rigidity and delineation of a dopamine-specific neostriatal subregion: tonic EMG activity in rats. Ellenbroek, B., Schwarz, M., Sontag, K.H., Jaspers, R., Cools, A. Brain Res. (1985)
- The effects of amfonelic acid, a dopamine uptake inhibitor, on methamphetamine-induced dopaminergic terminal degeneration and astrocytic response in rat striatum. Pu, C., Fisher, J.E., Cappon, G.D., Vorhees, C.V. Brain Res. (1994)
- Disruption of neostriatal development in rats following perinatal exposure to mild, but chronic carbon monoxide. Fechter, L.D., Karpa, M.D., Proctor, B., Lee, A.G., Storm, J.E. Neurotoxicology and teratology. (1987)
- The effects of megadose methylprednisolone and U-78517F on toxicity mediated by glutamate receptors in the rat neostriatum. Uhler, T.A., Frim, D.M., Pakzaban, P., Isacson, O. Neurosurgery (1994)
- Regulation by the neuropeptide cholecystokinin (CCK-8S) of protein phosphorylation in the neostriatum. Snyder, G.L., Fisone, G., Morino, P., Gundersen, V., Ottersen, O.P., Hökfelt, T., Greengard, P. Proc. Natl. Acad. Sci. U.S.A. (1993)
- Somatostatin is increased in the basal ganglia in Huntington disease. Aronin, N., Cooper, P.E., Lorenz, L.J., Bird, E.D., Sagar, S.M., Leeman, S.E., Martin, J.B. Ann. Neurol. (1983)
- Involvement of GABA systems in feedback regulation of glutamate-and GABA-mediated synaptic potentials in rat neostriatum. Calabresi, P., Mercuri, N.B., De Murtas, M., Bernardi, G. J. Physiol. (Lond.) (1991)
- Importance of glutamine for gamma-aminobutyric acid synthesis in rat neostriatum in vivo. Paulsen, R.E., Odden, E., Fonnum, F. J. Neurochem. (1988)
- Chronic blockade of muscarinic cholinergic receptors by systemic trihexyphenidyl (Artane) administration modulates but does not mediate the dopaminergic regulation of striatal prepropeptide messenger RNA expression. Mavridis, M., Rogard, M., Besson, M.J. Neuroscience (1995)
- Angiotensin injected into the neostriatum after learning disrupts retention performance. Morgan, J.M., Routtenberg, A. Science (1977)
- NGF receptor reexpression and NGF-mediated cholinergic neuronal hypertrophy in the damaged adult neostriatum. Gage, F.H., Batchelor, P., Chen, K.S., Chin, D., Higgins, G.A., Koh, S., Deputy, S., Rosenberg, M.B., Fischer, W., Bjorklund, A. Neuron (1989)
- Localization of D1 and D2 dopamine receptors in brain with subtype-specific antibodies. Levey, A.I., Hersch, S.M., Rye, D.B., Sunahara, R.K., Niznik, H.B., Kitt, C.A., Price, D.L., Maggio, R., Brann, M.R., Ciliax, B.J. Proc. Natl. Acad. Sci. U.S.A. (1993)
- Morphine and endorphins modulate dopamine turnover in rat median eminence. Deyo, S.N., Swift, R.M., Miller, R.J. Proc. Natl. Acad. Sci. U.S.A. (1979)
- A vitamin as neuromodulator: ascorbate release into the extracellular fluid of the brain regulates dopaminergic and glutamatergic transmission. Rebec, G.V., Pierce, R.C. Prog. Neurobiol. (1994)
- Opposing roles for D-1 and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatum. Stoof, J.C., Kebabian, J.W. Nature (1981)
- A novel cyclin provides a link between dopamine and RNA processing. Nairn, A.C., Greengard, P. Neuron (2001)
- Cdc42-interacting protein 4 binds to huntingtin: neuropathologic and biological evidence for a role in Huntington's disease. Holbert, S., Dedeoglu, A., Humbert, S., Saudou, F., Ferrante, R.J., Néri, C. Proc. Natl. Acad. Sci. U.S.A. (2003)
- Changes of NMDA receptor subunit (NR1, NR2B) and glutamate transporter (GLT1) mRNA expression in Huntington's disease--an in situ hybridization study. Arzberger, T., Krampfl, K., Leimgruber, S., Weindl, A. J. Neuropathol. Exp. Neurol. (1997)
- Differential regulation of the expression of nerve growth factor, brain-derived neurotrophic factor, and neurotrophin-3 after excitotoxicity in a rat model of Huntington's disease. Canals, J.M., Marco, S., Checa, N., Michels, A., Pérez-Navarro, E., Arenas, E., Alberch, J. Neurobiol. Dis. (1998)
- Androgen receptor, estrogen receptor alpha, and estrogen receptor beta show distinct patterns of expression in forebrain song control nuclei of European starlings. Bernard, D.J., Bentley, G.E., Balthazart, J., Turek, F.W., Ball, G.F. Endocrinology (1999)
- The alpha and gamma 1 isoforms of protein phosphatase 1 are highly and specifically concentrated in dendritic spines. Ouimet, C.C., da Cruz e Silva, E.F., Greengard, P. Proc. Natl. Acad. Sci. U.S.A. (1995)
- Differential cholinergic regulation of dopamine release in the dorsal and ventral neostriatum of the rat: an in vivo microdialysis study. O'Connor, W.T., Drew, K.L., Ungerstedt, U. J. Neurosci. (1995)
- An in vivo model for studying function of brain tissue temporarily devoid of glial cell metabolism: the use of fluorocitrate. Paulsen, R.E., Contestabile, A., Villani, L., Fonnum, F. J. Neurochem. (1987)
- Intranasal administration of the dopaminergic agonists L-DOPA, amphetamine, and cocaine increases dopamine activity in the neostriatum: a microdialysis study in the rat. De Souza Silva, M.A., Mattern, C., Häcker, R., Nogueira, P.J., Huston, J.P., Schwarting, R.K. J. Neurochem. (1997)
- Workshop on schizophrenia, PET, and dopamine D2 receptors in the human neostriatum. Andreasen, N.C., Carson, R., Diksic, M., Evans, A., Farde, L., Gjedde, A., Hakim, A., Lal, S., Nair, N., Sedvall, G. Schizophrenia bulletin. (1988)